Strategic Partnerships with the Pharmaceutical Sector Advancing Public Health Systems for SRHR
Advancing Public Health Systems for SRHR
JOICFP works in close collaboration with global pharmaceutical companies to expand access to quality health services in underserved communities. Through public-private partnerships, we strengthen health systems, empower communities, and improve access to the information and quality services of SRHR including maternal and adolescent health, cervical cancer prevention, and sexual and gender-based violence prevention and care.
Our Public–Private Partnership Model
JOICFP works at three interconnected levels to create sustainable health impact:
1. Health System Strengthening
Build stronger community-operated health systems by investing in health worker skills and scaling up health facility infrastructure in partnership with ministries of health and local governments.
2. Community Engagement & Demand Creation
Empower communities to increase health awareness, seek preventive care, access early detection services, and pursue timely treatment and care, working with key community stakeholders such as community leaders, community health volunteers, youth champions, and teachers.
3. Sustainable Integration
Integrate interventions into local governance and national health policy frameworks to ensure lasting ownership, financing, and continuity beyond project implementation periods.
Key Areas of Collaboration
- Maternal, newborn, child and adolescent health (MNCAH)
- Cervical cancer prevention through screening and early treatment
- Sexual gender-based violence (SGBV) prevention and care
Featured Partnership Projects
Cervical Cancer Prevention in Kenya
Strengthening early detection and treatment systems in collaboration with Nairobi County Department of Health.
Implementation Period: July 2022 – June 2025
Funding Partner: Daiichi Sankyo Co., Ltd.
MNCH Community Empowerment in Ghana
Improving maternal, newborn and child health outcomes through community-driven approaches in collaboration with Ghana Health Services (GHS).
Implementation Period: June 2023 – May 2026
Funding Partner: Shionogi & Co., Ltd. (Mother to Mother SHIONOGI Project)
Protecting the Lives of Pregnant Women in Africa
A multi-country initiative strengthening health systems for sexual and reproductive health across Ghana, Kenya, Tanzania, and Zambia in collaboration with national Ministries of Health.
Implementation Period: January 2018 – December 2022
Funding Partner: Takeda Pharmaceutical Company (Global CSR Program)
Impact Across Partnerships
Through strategic collaboration with pharmaceutical partners and public health authorities, JOICFP has contributed to:
- Strengthening public health systems across multiple African countries
- Advancing maternal, newborn, child and adolescent health outcomes
- Expanding access to cervical cancer screening and early treatment services
- Enhancing the capacity of frontline health workers
- Promoting community engagement and health-seeking behaviors
Contributing to Global Health and ESG Goals
Our partnerships contribute directly to:
- SDG 3: Good Health and Well-being
- SDG 5: Gender Equality
- SDG 17: Partnership
- Universal Health Coverage (UHC)
- Corporate ESG and sustainability commitments
Explore Partnership Opportunities
JOICFP welcomes collaboration with pharmaceutical companies seeking to strengthen health systems in low- and middle-income countries, expand access to preventive care, advance women’s health and reproductive rights, and demonstrate measurable social impact through responsible and sustainable partnerships.
